Capitalist Science
arxiv.org
Capitalist Science
1–10 of 82 posts
Re: Capitalist Science
#2Re: Capitalist Science
#3That's also why I dislike the term "data scientist". I'm not a scientist, because I'm not impartially searching for truth. I'll ignore avenues of inquiry that aren't profitable. It's my job to do so. I'm more of a data technologist, in truth.
Re: Capitalist Science
#4Re: Capitalist Science
#5Re: Capitalist Science
#6(I would observe, in semi-reply to many people in this thread, that incremental improvement and the relative drudgery of bringing tech to market manifested in real, concrete objects is actually very important. A system that only did "fundamental" research would produce an impoverished society every bit as much as a system that does nothing but "capitalist" work... and measured in man-hours, the "capitalist" work is often harder and longer than the fundamental research. You can tell because small teams can make "fundamental" breakthroughs but the actual act of bringing to market requires further engineering, design, integration into existing large engineered systems, logistics, scaling work, etc.)
Re: Capitalist Science
#7Re: Capitalist Science
#8Re: Capitalist Science
#9Contradiction in terms, given that blue-sky, basic research has gone away in industry and academia and it's capitalism's fault. Capitalism is great at technology and incremental innovation, but bad at science. This sort of thing is why a functional society needs some aspects of both (socialism and communism) in it. That's also why I dislike the term "data scientist". I'm not a scientist, because I'm not impartially s…
Why would you say that (a) Capitalism has caused basic research to go away, and (b) that it's bad at science in general?
Added later: after a moment's thought, it seems to me that we have a great example in head-to-head competition. In the competition between private and government-run science in the Human Genome Project, it seems pretty clear which side played the greater role.
Re: Capitalist Science
#10Except where the benefit goes to the capital, ready to charge you $20 for a publicly founded research paper.